Wells Fargo & Company Repligen Corp Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Repligen Corp stock. As of the latest transaction made, Wells Fargo & Company holds 9,189 shares of RGEN stock, worth $1.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,189

Previous 14,734 37.63%

Holding current value

$1.11 Million

Previous $2.65 Million 36.2%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$170.78 - $208.42 $946,975 - $1.16 Million	-5,545 Reduced 37.63%	9,189 $1.69 Million
Q4 2023 Feb 09, 2024	SELL	$114.17 - $185.35 $2.01 Million - $3.26 Million	-17,573 Reduced 54.39%	14,734 $2.65 Million
Q3 2023 Nov 13, 2023	BUY	$138.78 - $176.51 $224,129 - $285,063	1,615 Added 5.26%	32,307 $5.14 Million
Q2 2023 Aug 15, 2023	SELL	$138.42 - $180.31 $504,817 - $657,590	-3,647 Reduced 10.62%	30,692 $4.34 Million
Q1 2023 May 12, 2023	SELL	$154.26 - $198.1 $66,177 - $84,984	-429 Reduced 1.23%	34,339 $5.78 Million

Q4 2022 Feb 13, 2023	BUY	$162.42 - $220.56 $477,677 - $648,666	2,941 Added 9.24%	34,768 $5.89 Million
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $1.68 Million - $2.68 Million	-10,476 Reduced 24.76%	31,827 $5.96 Million
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $2.71 Million - $3.62 Million	-19,244 Reduced 31.27%	42,303 $6.87 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $2.16 Million - $3.46 Million	13,409 Added 27.86%	61,547 $11.6 Million
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $209 Million - $257 Million	-843,182 Reduced 94.6%	48,138 $12.7 Million
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $16.7 Million - $27.8 Million	-85,652 Reduced 8.77%	891,320 $258 Million
Q2 2021 Aug 16, 2021	BUY	$165.87 - $220.95 $12 Million - $16 Million	72,192 Added 7.98%	976,972 $195 Million
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $2.02 Million - $2.54 Million	11,209 Added 1.25%	904,780 $176 Million
Q4 2020 Feb 09, 2021	BUY	$148.08 - $206.57 $10.6 Million - $14.8 Million	71,681 Added 8.72%	893,571 $171 Million
Q3 2020 Nov 05, 2020	BUY	$122.51 - $158.27 $9.76 Million - $12.6 Million	79,706 Added 10.74%	821,890 $121 Million
Q2 2020 Aug 13, 2020	SELL	$94.33 - $140.48 $1.09 Million - $1.62 Million	-11,509 Reduced 1.53%	742,184 $91.7 Million
Q1 2020 May 14, 2020	BUY	$84.96 - $109.14 $64 Million - $82.3 Million	753,693 New	753,693 $72.8 Million

Others Institutions Holding RGEN

# of Institutions

521

Shares Held

53.2M

Call Options Held

1.05M

Put Options Held

228K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.7B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Repligen Corp Transaction History